Finally, using Kaplan-Meier analysis, we were able to determine that the survival of glioma patients with low tumor RSK2 expression is significantly higher than that of glioma patients that have high RSK2 expression in their tumors. This evidence concerns the gene RPS6KA3 and neoplasm.